Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 397 of 6351
-
New trial aims to wipe out hidden leukemia before transplant
Disease control Not yet recruitingThis phase II MyeloMATCH treatment trial compares cytarabine versus (vs.) cytarabine and venetoclax vs. liposome-encapsulated daunorubicin-cytarabine and venetoclax vs. azacitidine and venetoclax for treating patients who have residual disease after treatment for acute myeloid le…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug duo aims to shrink breast tumors before surgery
Disease control Not yet recruitingThis is a prospective, open-label, single-center, randomized controlled Phase II clinical study aimed at evaluating the efficacy and safety of neoadjuvant imlunestrant combined with abemaciclib guided by the Ki67 index after 2 weeks in patients with ER+/HER2- breast cancer.
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Engineered immune cells aim to tame stubborn autoimmune diseases
Disease control Not yet recruitingThis study is a single-arm, intervention, dose-escalation clinical trial to evaluate the safety of allogeneic CD19/BCMA-targeted CAR-γδT cell in the treatment of relapsed/refractory autoimmune diseases
Phase 1 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New proton therapy trial aims to reduce side effects in nasopharyngeal cancer
Disease control Not yet recruitingProton therapy for nasopharyngeal carcinoma can reduce radiotherapy-related toxic reactions, and some retrospective studies have found that proton therapy improves the survival of patients with nasopharyngeal carcinoma. However, high-level prospective clinical evidence is still l…
Sponsor: Guangzhou Concord Cancer Center • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Exercise program aims to boost strength in young cancer patients
Symptom relief Not yet recruitingThe BEPPO study is a Germany-wide clinical trial investigating whether a structured exercise program can improve physical and mental health in children and adolescents undergoing cancer treatment. Although exercise is known to support recovery and well-being, it is not yet a stan…
Sponsor: Universität Duisburg-Essen • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New drug cocktail aims to make ovarian tumors operable
Disease control Not yet recruitingThis is a single-center, single-arm clinical study to evaluate the efficacy and safety of iparomlimab and tovorilimab (QL1706) combined with paclitaxel, carboplatin, and bevacizumab as neoadjuvant therapy for advanced ovarian cancer.
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a neck surgery slow Alzheimer's? new trial aims to find out
Disease control Not yet recruitingThis is a multicenter, prospective, open-label, endpoint-blinded randomized controlled clinical study. We aim to evaluate the safety and efficacy of deep cervical lymphovenous anastomosis (LVA) combined with routine treatment for patients with moderate Alzheimer's disease, compar…
Sponsor: Southwest Hospital, China • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
Could less radiation be enough for some lymphoma patients?
Disease control Recruiting nowThis study is designed to evaluate the efficacy and safety of reduced-intensity radiotherapy for stage I/II low-risk nasal-type NK/T-cell lymphoma that has achieved complete remission after chemotherapy.
Phase 2 • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Smart insulin pump could transform hospital diabetes care
Disease control Not yet recruitingAim The investigators aim to investigate if automated insulin delivery systems (AID) improve in-hospital glycemic and clinical outcomes in patients with type 2 diabetes compared to standard-of-care with a pen-basal-bolus insulin regimen manually titrated by general staff at Herl…
Sponsor: Steno Diabetes Center Copenhagen • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Targeted magnetic pulses aim to lift bipolar depression
Symptom relief Not yet recruitingThis study is exploring a new approach to treating depression in people with bipolar disorder (BD). Investigators are testing whether a non-invasive form of brain stimulation can help us understand depressed-to-euthymic mood shifts and their related brain circuits in BD. Investi…
Phase 4 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Jul 04, 2026 00:00 UTC
-
Targeted drug combo aims to shrink Hard-to-Treat head and neck tumors
Disease control Not yet recruitingThis is a prospective, open-label, non-randomized, two-cohort, single-arm Phase 2 study in adults with unresectable or recurrent/metastatic head and neck squamous cell carcinoma, excluding nasopharyngeal carcinoma. The study will evaluate the efficacy and safety of Becotatug vedo…
Phase 2 • Sponsor: Feng Liu • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
AI could help doctors pick better diabetes drugs
Disease control Not yet recruitingThis study tests whether an artificial intelligence (AI) tool can help doctors choose better diabetes medicines for their patients. Type 2 diabetes is very common, but there are far more patients than diabetes specialists, so many patients are treated by doctors who are not diabe…
Sponsor: National Taiwan University Hospital • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Spinal pain pump may offer relief for cancer patients when opioids fail
Symptom relief Recruiting nowApproximately 66% of patients with advanced cancer experience pain, which is often inadequately controlled and associated with a decline in health-related quality of life (HRQoL). Conventional pharmacologic management, ranging from simple analgesics to strong opioids, is frequent…
Sponsor: Universitair Ziekenhuis Brussel • Aim: Symptom relief
Last updated Jul 11, 2026 00:00 UTC
-
Bispecific antibody shows promise for Hard-to-Treat lymphoma in Real-World study
Disease control Not yet recruitingB-cell non-Hodgkin lymphoma (B-NHL) is the most common type of lymphoma. Although first-line R-CHOP can cure a proportion of patients, approximately 30%-40% relapse or become refractory (R/R). CD20xCD3 bispecific antibodies, represented by glofitamab, have shown significant effic…
Sponsor: Yanyan Liu • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
New anesthetic may keep blood pressure steadier during stroke clot removal
Disease control Not yet recruitingEndovascular therapy (EVT) improves the prognosis of patients with acute ischemic stroke (AIS). EVT has been established as a standard of care for AIS caused with large vessel occlusion based on numerous randomized controlled trials. However, despite extensive attention to post-E…
Phase 4 • Sponsor: RenJi Hospital • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a gentle surgical approach improve outcomes after deep brain bleeding?
Disease control Not yet recruitingThis observational cohort study evaluates the real-world effectiveness and safety of minimally invasive surgery (MIS) versus standard medical management in adults with spontaneous deep intracerebral hemorrhage. Patients presenting to Tam Anh General Hospital and People's Hospital…
Sponsor: Tam Anh Research Institute • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Can a nasal spray of insulin shield the aging brain from Post-Surgery confusion?
Prevention Not yet recruitingPostoperative delirium (POD) is highly prevalent in older patients with type 2 diabetes mellitus (T2DM). Cerebral insulin resistance is considered a key pathophysiological mechanism underlying this association. This study aims to investigate whether intranasal insulin (INI) can p…
Sponsor: Weidong Mi • Aim: Prevention
Last updated Jul 24, 2026 00:00 UTC
-
Can a new daily pill slow advanced prostate cancer?
Disease control Recruiting nowThe goal of this clinical trial is to find out if FX-111 is safe enough to permit further studies in adult male participants with metastatic castration-resistant prostate cancer (mCRPC). It will also study the drug's pharmacokinetics (how the body breaks down FX-111) and how well…
Phase 1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Can robots perfectly align broken femurs?
Disease control Recruiting nowThe goal of this clinical trial is to evaluate the safety and efficacy of robot-assisted closed reduction for patients with femoral shaft fractures. The main questions it aims to answer are: Does robot-assisted closed reduction provide a statistically significant improvement in …
Sponsor: Beijing Jishuitan Hospital • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can a daily probiotic soothe colicky babies and calm eczema?
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether daily probiotic supplementation with Bifidobacterium bifidum (Bifipral® drops) can reduce crying time in formula-fed infants aged 5 months or younger diagnosed with infant colic (according to Rome IV criteria), with or withou…
Sponsor: University of Roma La Sapienza • Aim: Symptom relief
Last updated Aug 12, 2026 00:00 UTC